Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by amendison Jun 09, 2015 12:46pm

103 Views

Post# 23811437

Two new antigens

MBX increase the antigens portfolio two more Product. I think this is very good news. MBX going to give news more often. every time before news comes. SP goes down. The news comes MBX goes up. So I put for.54 so far partly sold hopping to sell the rest, This is a solid stock nothing to worry to hold

Bullboard Posts

Eminent acquires promising Nevada gold project